Yunxin Lai
State Key Laboratory Of Respiratory Disease
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
PHB2 acts as a braker of progressive pulmonary fibrosis via intervention of DDR2-elicited signaling.
PHB2 acts as a braker of progressive pulmonary fibrosis via intervention of DDR2-elicited signaling.
Journal: Acta biochimica et biophysica Sinica
Published: March 18, 2026
Correction: Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells.
Journal: Journal of hematology & oncology
Published: February 25, 2025
Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration.
Journal: BMJ open respiratory research
Published: December 03, 2022
Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases.
Journal: American journal of respiratory and critical care medicine
Published: August 19, 2022
Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases.
Journal: Frontiers in immunology
Published: July 26, 2021
Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis.
Journal: The European respiratory journal
Published: March 23, 2021
The Exocrine Differentiation and Proliferation Factor (EXDPF) Gene Promotes Ovarian Cancer Tumorigenesis by Up-Regulating DNA Replication Pathway.
Journal: Frontiers in oncology
Published: February 19, 2021
Correction to: A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia.
Journal: Journal of hematology & oncology
Published: November 22, 2019
A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia.
Journal: Journal of hematology & oncology
Published: January 04, 2018
Current status and perspectives of patient-derived xenograft models in cancer research.
Journal: Journal of hematology & oncology
Published: March 15, 2017
CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg-/- Mice Results in Severe Immunodeficiency.
CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg-/- Mice Results in Severe Immunodeficiency.
Journal: Scientific reports
Published: March 07, 2017
PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells.
Journal: Oncoimmunology
Published: December 21, 2016
Last Updated: 09/26/2026